Scott P Commins Selected Research

Oligosaccharides

1/2021	Tick salivary gland extract induces alpha-gal syndrome in alpha-gal deficient mice.
1/2021	Alpha-Gal Syndrome: Involvement of Amblyomma americanum α-D-Galactosidase and β-1,4 Galactosyltransferase Enzymes in α-Gal Metabolism.
9/2020	Association between lone star tick bites and increased alpha-gal sensitization: evidence from a prospective cohort of outdoor workers.
1/2020	Diagnosis & management of alpha-gal syndrome: lessons from 2,500 patients.
1/2020	On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy.
9/2019	Investigation into the α-Gal Syndrome: Characteristics of 261 Children and Adults Reporting Red Meat Allergy.
1/2019	Discovery of Alpha-Gal-Containing Antigens in North American Tick Species Believed to Induce Red Meat Allergy.
1/2018	IgE to the Mammalian Oligosaccharide Galactose-α-1,3-Galactose Is Associated With Increased Atheroma Volume and Plaques With Unstable Characteristics-Brief Report.
1/2016	Delayed anaphylaxis to alpha-gal, an oligosaccharide in mammalian meat.
1/2016	IgE in the diagnosis and treatment of allergic disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott P Commins Research Topics

Disease

27	Anaphylaxis (Anaphylactic Shock) 01/2021 - 02/2009
18	red meat allergy 12/2022 - 12/2013
17	Hypersensitivity (Allergy) 01/2021 - 02/2013
11	Tick Bites 09/2020 - 05/2011
9	Food Hypersensitivity (Food Allergy) 01/2019 - 02/2009
6	Eosinophilic Esophagitis 01/2021 - 11/2015
5	Bites and Stings (Sting) 01/2021 - 12/2013
4	Urticaria (Hives) 01/2021 - 02/2009
4	Asthma (Bronchial Asthma) 01/2016 - 04/2012
2	Angioedema 04/2012 - 02/2009
1	Dermatitis 03/2021
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2021
1	Rare Diseases (Rare Disease) 09/2019
1	Atherosclerotic Plaque (Atheroma) 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Diabetes Mellitus 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Milk Hypersensitivity (Milk Allergy) 05/2016
1	Mycoses (Diseases, Fungus) 01/2016

Drug/Important Bio-Agent (IBA)

38	Immunoglobulin E (IgE)IBA 01/2021 - 02/2009
17	OligosaccharidesIBA 01/2021 - 05/2011
15	AntibodiesIBA 01/2021 - 02/2009
13	AllergensIBA 01/2021 - 10/2009
9	CarbohydratesIBA 01/2019 - 02/2009
8	EpitopesIBA 01/2019 - 02/2009
8	Cetuximab (Erbitux)FDA Link 01/2016 - 01/2010
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2011
3	AntigensIBA 12/2022 - 04/2015
3	Galactose (Galactopyranose)FDA LinkGeneric 01/2020 - 02/2013
3	Immunoglobulin G (IgG)IBA 09/2019 - 01/2016
2	LipidsIBA 01/2021 - 01/2019
2	EnzymesIBA 01/2021 - 01/2020
2	GlycolipidsIBA 01/2020 - 02/2013
2	Monoclonal AntibodiesIBA 05/2015 - 01/2010
1	Transcription Factors (Transcription Factor)IBA 03/2021
1	COVID-19 VaccinesIBA 01/2021
1	GalactosidasesIBA 01/2021
1	GalactosyltransferasesIBA 01/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2021
1	PowdersIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	Ethylene Oxide (Oxirane)IBA 11/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	Herpes Zoster VaccineIBA 01/2017
1	Milk Proteins (Milk Protein)IBA 01/2016
1	Pharmaceutical PreparationsIBA 02/2014
1	Blood Group Antigens (Blood Groups)IBA 12/2013
1	Glycoproteins (Glycoprotein)IBA 02/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2012

Therapy/Procedure

3	Immunotherapy 01/2021 - 05/2016
3	Therapeutics 01/2021 - 05/2016
1	Investigational Therapies (Experimental Therapy) 05/2016